AEKYUNG CHEMICAL cancels stock options for one grantee, reducing shares by 6,783; slight relief from dilution

AEKYUNG CHEMICAL filed a correction on June 1, 2026, canceling the stock option grant for one recipient from the original 2020 grant.
As a result, the number of grantees decreased from 6 to 5, and the number of shares granted dropped from 46,965 to 40,182, a reduction of 6,783 shares.
The canceled 6,783 shares represent only about 0.014% of total outstanding shares (48,648,709), so the dilution relief is negligible.
Some remaining options (including CEO Lim Jae-young and 3 others) have already been exercised, limiting further dilution risk.
[AI Summary]This cancellation of stock options is marginally positive for existing shareholders, but the small scale means it will not materially affect the stock price. It does, however, enhance transparency in executive compensation.